Author(s):
Devulapally Shravya, Jorige Archana
Email(s):
archanacology@gmail.com
DOI:
10.52711/2231-5675.2024.00012 
Address:
Devulapally Shravya1, Jorige Archana2*
1Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Osmania University, Hyderabad, 500027, Telangana, India.
2Department of Pharmacology, RBVRR Women’s College of Pharmacy, Osmania University, Hyderabad, 500027, Telangana, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 2,
Year - 2024
ABSTRACT:
In Asia, Favipiravir, an anti- influenza medication, is widely available. Although having little proof of effectiveness, it has been widely utilised in the treatment of COVID-19. A simple UV spectroscopic method was developed for the determination of Favipiravir in pharmaceutical formulations. Favipiravir exhibited maximum absorption at 228 nm in 90% Ethanol and obeyed linearity in the concentration range of 0.5-25µg/ml. The proposed method was statistically validated. The % RSD < 2% indicates that method is precise. The % recovery results for accuracy in three levels i.e., 50%, 100% and 150% are 99.7, 99.7 and 99.8. Limits of detection and quantification were found to be 0.0435µg and 0.1318µg respectively. The ruggedness of method was studied with the help of different analyst. The robustness was performed in different 227 and 229nm. The developed UV method was validated and it was rapid, simple, sensitive and cost effective.
Cite this article:
Devulapally Shravya, Jorige Archana. A New Validated UV Spectroscopic Method for the Estimation of Favipiravir, an anti-influenza drug in COVID 19. Asian Journal of Pharmaceutical Analysis. 2024; 14(2):65-8. doi: 10.52711/2231-5675.2024.00012
Cite(Electronic):
Devulapally Shravya, Jorige Archana. A New Validated UV Spectroscopic Method for the Estimation of Favipiravir, an anti-influenza drug in COVID 19. Asian Journal of Pharmaceutical Analysis. 2024; 14(2):65-8. doi: 10.52711/2231-5675.2024.00012 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-2-3
REFERENCES:
1. Singh P, Gupta E, Mishra N, Mishra P. Shikimic acid as intermediary model for the production of drugs effective against influenza virus. In Phytochemicals as Lead Compounds for New Drug Discovery. 2020 Jan 1: 245-256.
2. Agrawal U, Raju R, Udwadia ZF. Favipiravir: A new and emerging antiviral option in COVID-19. Medical Journal Armed Forces India. 2020 Oct 1; 76(4): 370-6.
3. Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research. 2013 Nov 1; 100(2): 446-54.
4. Baranovich T, Wong SS, Armstrong J, Marjuki H, Webby RJ, Webster RG, Govorkova EA. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. Journal of Virology. 2013 Apr 1; 87(7): 3741-51.
5. Jain MS, Barhate SD. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19: A review. Asian Journal of Pharmaceutical Research. 2021; 11(1): 39-42.
6. Ritika Gupta. The Management of Coronavius Pandemic 2019-2020. Asian J. Pharm. Res. 2020; 10(4): 327-330.
7. Rajan VR, Prathamesh PT. Simple Extractive Spectrophotometric Method for Determination of Favipiravir from Pharmaceutical Formulation. Asian Journal of Research in Chemistry. 2022 Jul 1; 15(4): 299-302.
8. Manda P, Jorige A. A new validated spectroscopic method for the estimation of sodium benzoate in soft drinks. Asian Journal of Pharmaceutical Analysis. 2022; 12(1): 13-6.
9. Favipiravir; [cited 2022 May14]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Favipiravir
10. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic acids research. 2006 Jan 1; 34(suppl_1): D668-72.
11. International Conference on Harmonization (ICH) Guidelines Q2 (R1), Validation of Analytical Procedures: Text and Methodology, 1996: 1-17.
12. Shinde G, Godage RK, Jadhav RS, Manoj B, Aniket B. A Review on Advances in UV Spectroscopy. Research Journal of Science and Technology. 2020; 12(1): 47-51.
13. Benazir SB, Archana J, Sumakanth M. Method development and validation of empagliflozin in bulk and pharmaceutical dosage form using UV spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(2): 123-6.
14. Sahoo CK, Sudhakar M, Ramana DV, Satyanarayana K, Panda KC. Validation of analytical procedures-A review. Asian Journal of Pharmaceutical Analysis. 2018; 8(2): 109-16.
15. Rele RV, Tiwatane PP. Determination of Favipiravir from Pharmaceutical Dosage Form by Extractive Ion Pair Complex Colorimetric Method. Asian Journal of Research in Chemistry. 2021; 14(5): 321-323.
16. Kalshetti MS, Adlinge SG. Development and validation of HPLC method for quantification of favipiravir in tablet. Research Journal of Pharmacy and Technology. 2022; 15(3): 1319-22.